Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Revista colombiana de Gastroenterología
versión impresa ISSN 0120-9957versión On-line ISSN 2500-7440
Resumen
OLIVEROS, Ricardo; SIERRA-PRIETO, Jonathan; BONILLA-GONZALEZ, Carlos y MESA-LOPEZ DE MESA, Jorge Andrés. Importance of HER2 status determination in advanced gastric cancer: A case study. Rev. colomb. Gastroenterol. [online]. 2021, vol.36, suppl.1, pp.2-10. Epub 18-Feb-2022. ISSN 0120-9957. https://doi.org/10.22516/25007440.503.
Advanced gastric cancer (AGC) is an entity that encompasses two distinct clinical situations: locally advanced unresectable gastric cancer and metastatic disease, with chemotherapy as the standard treatment. HER2 overexpression can occur in 9% to 38% of the cases with this disease and has been the first predictive biomarker used for trastuzumab-targeted therapy in patients with advanced gastric and gastroesophageal tumors. This article presents a patient with AGC and positive HER2 treated with conventional chemotherapy plus trastuzumab as targeted therapy with adequate clinical response.
Palabras clave : Advanced gastric cancer; Treatment; Trastuzumab; HER2.